Stay updated with breaking news from Numinus Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical...
Numinus Wellness has submitted CTA to Health Canada to commence Phase I trial of NBIO-01 for psychedelic-assisted therapies.
/PRNewswire/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to announce that it has formally...
The formulation has been developed to stably deliver psilocybin and other synergistic compounds and will be studied for safety and...
/PRNewswire/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to announce that it has formally...